Cargando…

Prioritization of Vaccines for Inclusion into China’s Expanded Program on Immunization: Evidence from Experts’ Knowledge and Opinions

Background: Vaccine developers in China have made an increasing number of infectious diseases preventable through vaccination. An appropriate decision-making procedure is necessary for making wise decisions on whether to introduce new vaccines into the Expanded Program on Immunization (EPI). When th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Chao, Li, Junhong, Wang, Nan, Wang, Yamin, Song, Yudan, Zeng, Xiang, Zheng, Canjun, An, Zhijie, Rodewald, Lance, Yin, Zundong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318118/
https://www.ncbi.nlm.nih.gov/pubmed/35891174
http://dx.doi.org/10.3390/vaccines10071010
_version_ 1784755212970360832
author Ma, Chao
Li, Junhong
Wang, Nan
Wang, Yamin
Song, Yudan
Zeng, Xiang
Zheng, Canjun
An, Zhijie
Rodewald, Lance
Yin, Zundong
author_facet Ma, Chao
Li, Junhong
Wang, Nan
Wang, Yamin
Song, Yudan
Zeng, Xiang
Zheng, Canjun
An, Zhijie
Rodewald, Lance
Yin, Zundong
author_sort Ma, Chao
collection PubMed
description Background: Vaccine developers in China have made an increasing number of infectious diseases preventable through vaccination. An appropriate decision-making procedure is necessary for making wise decisions on whether to introduce new vaccines into the Expanded Program on Immunization (EPI). When there are several vaccines that could potentially be considered, a scientifically justifiable mechanism is needed for prioritizing and sequencing vaccines for consideration. Methods: We used a modified Delphi technique (MDT) to develop and refine an indicator system to prioritize vaccines and make policy recommendations concerning their introduction into China’s EPI system. From January through May 2021, thirty-nine experts were recruited and participated in a two-round Delphi survey that was based on a set of candidate indicators obtained through a literature review and reference to the WHO vaccine introduction recommendations. Using the resulting indicator system, we conducted a third consultation with a multi-disciplinary group of experts who scored five program-eligible candidate vaccines to determine prioritization and sequencing for consideration of inclusion into the EPI. Results: Response rates of the thirty-nine experts were 100% and 97.4% across the two rounds. Authority coefficients from rounds one to three were over 0.70, reflecting the high accuracy and reliability of the consultation. Coordination coefficients of importance scores for primary, secondary, and tertiary indicators were 0.486, 0.356, 0.275 in round one, and 0.405, 0.340, and 0.236 in round two. According to the scores from 30 experts using our indicator system, the sequence and scores (1–10 scale, 10 highest) of 5 candidate vaccines were varicella (6.91), meningococcal conjugate AC (6.83), Hib (6.74), influenza (6.56), and EV71 (6.17) vaccines. Conclusions: A modified Delphi technique effectively built a scientific, rational, comprehensive, and systematic indicator system for prioritizing vaccine candidates for consideration of inclusion into the EPI. The rank order will be used by the technical working groups of China’s National Immunization Advisory Committee to sequentially develop and present Evidence-to-Recommendation tables for making policy recommendations.
format Online
Article
Text
id pubmed-9318118
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93181182022-07-27 Prioritization of Vaccines for Inclusion into China’s Expanded Program on Immunization: Evidence from Experts’ Knowledge and Opinions Ma, Chao Li, Junhong Wang, Nan Wang, Yamin Song, Yudan Zeng, Xiang Zheng, Canjun An, Zhijie Rodewald, Lance Yin, Zundong Vaccines (Basel) Article Background: Vaccine developers in China have made an increasing number of infectious diseases preventable through vaccination. An appropriate decision-making procedure is necessary for making wise decisions on whether to introduce new vaccines into the Expanded Program on Immunization (EPI). When there are several vaccines that could potentially be considered, a scientifically justifiable mechanism is needed for prioritizing and sequencing vaccines for consideration. Methods: We used a modified Delphi technique (MDT) to develop and refine an indicator system to prioritize vaccines and make policy recommendations concerning their introduction into China’s EPI system. From January through May 2021, thirty-nine experts were recruited and participated in a two-round Delphi survey that was based on a set of candidate indicators obtained through a literature review and reference to the WHO vaccine introduction recommendations. Using the resulting indicator system, we conducted a third consultation with a multi-disciplinary group of experts who scored five program-eligible candidate vaccines to determine prioritization and sequencing for consideration of inclusion into the EPI. Results: Response rates of the thirty-nine experts were 100% and 97.4% across the two rounds. Authority coefficients from rounds one to three were over 0.70, reflecting the high accuracy and reliability of the consultation. Coordination coefficients of importance scores for primary, secondary, and tertiary indicators were 0.486, 0.356, 0.275 in round one, and 0.405, 0.340, and 0.236 in round two. According to the scores from 30 experts using our indicator system, the sequence and scores (1–10 scale, 10 highest) of 5 candidate vaccines were varicella (6.91), meningococcal conjugate AC (6.83), Hib (6.74), influenza (6.56), and EV71 (6.17) vaccines. Conclusions: A modified Delphi technique effectively built a scientific, rational, comprehensive, and systematic indicator system for prioritizing vaccine candidates for consideration of inclusion into the EPI. The rank order will be used by the technical working groups of China’s National Immunization Advisory Committee to sequentially develop and present Evidence-to-Recommendation tables for making policy recommendations. MDPI 2022-06-24 /pmc/articles/PMC9318118/ /pubmed/35891174 http://dx.doi.org/10.3390/vaccines10071010 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ma, Chao
Li, Junhong
Wang, Nan
Wang, Yamin
Song, Yudan
Zeng, Xiang
Zheng, Canjun
An, Zhijie
Rodewald, Lance
Yin, Zundong
Prioritization of Vaccines for Inclusion into China’s Expanded Program on Immunization: Evidence from Experts’ Knowledge and Opinions
title Prioritization of Vaccines for Inclusion into China’s Expanded Program on Immunization: Evidence from Experts’ Knowledge and Opinions
title_full Prioritization of Vaccines for Inclusion into China’s Expanded Program on Immunization: Evidence from Experts’ Knowledge and Opinions
title_fullStr Prioritization of Vaccines for Inclusion into China’s Expanded Program on Immunization: Evidence from Experts’ Knowledge and Opinions
title_full_unstemmed Prioritization of Vaccines for Inclusion into China’s Expanded Program on Immunization: Evidence from Experts’ Knowledge and Opinions
title_short Prioritization of Vaccines for Inclusion into China’s Expanded Program on Immunization: Evidence from Experts’ Knowledge and Opinions
title_sort prioritization of vaccines for inclusion into china’s expanded program on immunization: evidence from experts’ knowledge and opinions
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318118/
https://www.ncbi.nlm.nih.gov/pubmed/35891174
http://dx.doi.org/10.3390/vaccines10071010
work_keys_str_mv AT machao prioritizationofvaccinesforinclusionintochinasexpandedprogramonimmunizationevidencefromexpertsknowledgeandopinions
AT lijunhong prioritizationofvaccinesforinclusionintochinasexpandedprogramonimmunizationevidencefromexpertsknowledgeandopinions
AT wangnan prioritizationofvaccinesforinclusionintochinasexpandedprogramonimmunizationevidencefromexpertsknowledgeandopinions
AT wangyamin prioritizationofvaccinesforinclusionintochinasexpandedprogramonimmunizationevidencefromexpertsknowledgeandopinions
AT songyudan prioritizationofvaccinesforinclusionintochinasexpandedprogramonimmunizationevidencefromexpertsknowledgeandopinions
AT zengxiang prioritizationofvaccinesforinclusionintochinasexpandedprogramonimmunizationevidencefromexpertsknowledgeandopinions
AT zhengcanjun prioritizationofvaccinesforinclusionintochinasexpandedprogramonimmunizationevidencefromexpertsknowledgeandopinions
AT anzhijie prioritizationofvaccinesforinclusionintochinasexpandedprogramonimmunizationevidencefromexpertsknowledgeandopinions
AT rodewaldlance prioritizationofvaccinesforinclusionintochinasexpandedprogramonimmunizationevidencefromexpertsknowledgeandopinions
AT yinzundong prioritizationofvaccinesforinclusionintochinasexpandedprogramonimmunizationevidencefromexpertsknowledgeandopinions